Literature DB >> 20364028

Pelvic lymph nodes: distribution and nodal tumour burden of urothelial bladder cancer.

Roland Seiler1, Michael von Gunten, George N Thalmann, Achim Fleischmann.   

Abstract

AIMS: To evaluate the number of lymph nodes and the lymph node tumour burden in different anatomical pelvic regions to better asses the impact of variations in the extent of lymphadenectomy on reported LN parameters and pelvic tumour clearance.
METHODS: 162 patients with lymph-node-positive urothelial carcinoma of the bladder were treated by cystectomy and extended pelvic lymphadenectomy. Various lymph node parameters were determined separately for the three pelvic regions (external iliac, obturator and internal iliac).
RESULTS: Of 4,080 evaluated lymph nodes (median 25 per patient, range 8-55) 39%, 35% and 26% (p<0.05) were found in the external iliac, obturator and internal iliac region, respectively. The distribution of the 625 lymph node metastases (median two per patient, range 1-35) was not significantly different between the regions (external iliac 33%, obturator 38%, internal iliac 29%). However, the median diameter of largest metastasis and total diameter of all metastases were smallest in the internal iliac region (external iliac 0.85 cm, 1.1 cm; obturator 0.8 cm, 1.0 cm; internal iliac 0.6 cm, 0.8 cm; p<0.03, p<0.05; for median diameter of largest metastasis and total diameter of all metastases, respectively). Metastases in only one region were found in 33% of patients (external iliac 13%, obturator 10%, internal iliac 10%); these three groups showed no significant difference in survival. No difference was detected in lymph node parameters between genders.
CONCLUSIONS: Lymph node counts and retrieval of metastases depends on the extent of pelvic lymphadenectomy. Dissection not including the internal iliac region misses 26% of all pelvic lymph nodes, 29% of metastases, and understages a substantial number of patients as pN0 (10%).

Entities:  

Mesh:

Year:  2010        PMID: 20364028      PMCID: PMC2981017          DOI: 10.1136/jcp.2009.075077

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


Introduction

Up to 27% of surgically treated bladder cancer patients are found to have lymph node metastasis upon histological examination when an extended pelvic lymphadenectomy is performed.1–3 However, no consensus exists about the recommended surgical field of pelvic lymph node dissection,2 4 5 particularly about dissection of the internal iliac region. In anatomical studies, approximately 20 lymph nodes may be routinely found in the pelvis.6 The distribution of pelvic lymph node metastases from bladder cancers in different pelvic regions has previously been investigated in 812 and in 481 patients, respectively. Lymph node tumour burden was reported as the number of positive nodes; however, other parameters of metastases such as the largest diameter and total diameter were not. In this study, we determined these parameters in a single institution cohort of 162 patients with urothelial carcinoma of the bladder undergoing cystectomy and extended pelvic lymphadenectomy. The routine submission of the lymphadenectomy specimens from six pelvic regions (bilateral three regions) provides individual data from every region (external iliac, obturator and internal iliac). Different series7–9 of gender-specific pelvic cancers suggest a higher lymph node count in women than in men. Here, we analyse lymph node counts and characteristics of lymph node metastases in women and men undergoing standardised surgery for the same disease.

Material and methods

Patients

A standardised extended bilateral pelvic lymphadenectomy with cystectomy was performed in 840 patients with invasive bladder cancer between January 1985 and April 2008 at the Department of Urology, University of Bern. None of the patients received neoadjuvant therapy. One hundred and sixty-two (30 women, 132 men) of these patients with urothelial cancer of the bladder and without preoperative clinical evidence of metastases (physical examination, chest x-ray, bone scan, intravenous urography, and CT scan of the pelvis when it became available) had lymph node metastases upon pathological examination. All patients were followed prospectively.

Surgical technique

Bilateral pelvic lymphadenectomy was performed in all patients according to a standard protocol described previously by Mills.10 In short, all lymphatic and connective tissue was meticulously removed from the common iliac bifurcation along the external iliac vessels to the inguinal ligament. Anterolateral limits were the external iliac artery and the genitofemoral nerve (external iliac region). The obturator fossa was completely cleared of all tissue other than the obturator nerve (obturator region). The ventral aspect of the internal iliac vein as well as the internal iliac artery and branches were freed of all lymphatic and connective tissue (internal iliac region). The resected tissue of the six regions was sent separately in formalin for histological examination. The cystectomy protocol has previously been described in detail.11

Pathology

The cystectomy and lymph node specimens were examined by pathologists experienced in genitourinary pathology at the Institute of Pathology, University of Bern. All slides were reviewed by two pathologists (AF and MvG). The cystectomy and lymphadenectomy specimens were analysed according to a standard protocol described earlier.5 Tumour type, tumour stage, tumour grade and the presence of carcinoma in situ were histologically determined. All tumours were classified according to the sixth International Union Against Cancer (UICC) classification of 2002.12 For each pelvic region, the total number of histologically confirmed lymph nodes as well as the number and diameter of lymph node metastases (figure 1) were recorded.
Figure 1

Lymph node metastasis of urothelial bladder cancer. The largest diameter of all metastases was measured on slides.

Lymph node metastasis of urothelial bladder cancer. The largest diameter of all metastases was measured on slides.

Statistical analysis

Lymph node data for the three bilateral pelvic regions and results stratified for gender were compared using a two-sided Wilcoxon rank-sum test. Differences in outcome events between subgroups were analysed using a two-sided Fisher test. All analyses were performed using R software package, version 2.9.1.

Results

Characteristics of patients, cystectomy and lymphadenectomy specimens

Median age of the 162 lymph node positive patients (30 females, 132 males) at surgery was 67 years (range, 35–89 years; table 1). In general, patients had grade 3 tumours (n=157), and grade 2 tumours (n=5) were observed rarely. Most patients presented with advanced primary tumours (pT3/4; n=139) and advanced lymph node involvement (pN2; n=110). A median of 25 lymph nodes (range 8–55) and two metastases (range 1–35) per patient were identified in the three bilateral regions. Median follow-up of the cohort was 7.1 years; 96 patients relapsed, 115 died, and 88 died due to progressive disease. Survival was significantly different between pN1 and pN2 subgroups (p<0.05, table 2). No difference was observed between patients grouped according to isolated metastases in one of the three pelvic regions.
Table 1

Clinicopathological data of 162 nodal positive bladder cancer patients

Patient data
 Age (years) at surgery, median (range)67 (35–89)
 Female/male, n30/132
Cystectomy data: stage, n
 pT15
 pT218
 pT3a35
 pT3b62
 pT442
Lymphadenectomy data*
 Total no. of evaluated nodes, n4080
 No. of evaluated nodes per patient, median (range)25 (8–55)
 No. of positive nodes per patient, median (range)2 (1–35)
Lymph node stage, n
 pN152
 pN2110
 Diameter (cm) of largest metastasis per patient, median (range)1.0 (0.1–4.9)
 Total diameter (cm) of metastases per patient, median (range)1.4 (0.1–39.9)

Most primary tumours showed extravesical extension (pT3/4; n=139) and advanced lymph node tumour burden (pN2; n=110).

Data summarised for the three pelvic regions.

Table 2

Survival data of the cohort

Death from bladder cancerp ValueRecurrent cancerp Value
Lymph node tumour burden
 Lymph node stage, n (%)
 pN120/52 (38)<0.00424/52 (46)<0.004
 pN268/107 (62)77/110 (70)
 Diameter of largest metastasis, n (%)
 <Median40/79 (51)0.345/80 (56)0.1
 ≥Median48/80 (60)56/82 (68)
 Total diameter of metastases, n (%)
 <Median36/77 (47)<0.0442/79 (53)<0.04
 ≥Median52/82 (63)59/83 (71)
Pelvic region if isolated metastases, n (%)
 External iliac9/21 (43)1.0011/21 (52)1.00
 Obturator8/17 (47)9/17 (53)
 Internal iliac7/15 (41)9/17 (53)
Clinicopathological data of 162 nodal positive bladder cancer patients Most primary tumours showed extravesical extension (pT3/4; n=139) and advanced lymph node tumour burden (pN2; n=110). Data summarised for the three pelvic regions. Survival data of the cohort

Distribution of all lymph nodes in the three pelvic regions

In total, 4080 lymph nodes were detected in the three regions (table 3). Most of the lymph nodes recovered were in the external iliac (n=1599; 39%) and obturator region (n=1438; 35%). Significantly fewer nodes were dissected in the internal iliac region (n=1043; 26%; p<0.005).
Table 3

Lymph node data evaluated for the three pelvic regions

External iliac regionObturator regionInternal iliac region
Removed lymph nodes
 Total no. of lymph nodes, (%)1599 (39)1438 (35)1043 (26)*
 Median no. of lymph nodes per patient, (range)8 (0–43)8 (0–34)6 (0–18)
Lymph node metastases
 Total no. of metastases, (%)204 (33)238 (38)183 (29)
 Median no. of metastases per patient, (mean)1 (2.3)2 (2.8)1 (2.3)
 Median diameter (cm) of largest metastasis per patient0.850.80.6
 Median total diameter (cm) of all metastases per patient1.11.00.8§
 Total diameter (cm) of all metastases per region, (%)193 (40)191 (39)100 (21)

Most lymph nodes were detected in the external iliac region; lymph node tumour burden was lowest in the internal iliac region.

p<0.0001 (internal versus external; internal versus obturator).

17 patients with pelvic lymph node metastases solely in the internal iliac region.

p<0.03 (internal versus external; internal versus obturator).

p<0.05 (internal versus external).

Lymph node data evaluated for the three pelvic regions Most lymph nodes were detected in the external iliac region; lymph node tumour burden was lowest in the internal iliac region. p<0.0001 (internal versus external; internal versus obturator). 17 patients with pelvic lymph node metastases solely in the internal iliac region. p<0.03 (internal versus external; internal versus obturator). p<0.05 (internal versus external).

Frequency of lymph node metastases

Metastases were found in 625 lymph nodes (table 3). Their distribution in the external iliac, obturator and internal iliac region was 33%, 38% and 29%, respectively (p>0.05). Metastases in only one region were found in 33% of patients (external iliac, obturator and internal iliac region in 13%, 10% and 10% of the patients, respectively); 50% of all patients had lymph node metastases in the internal iliac region.

Lymph node tumour burden in the three pelvic regions

Median diameter of the largest metastasis per patient and median total diameter of all metastases per patient were similar in the external iliac (0.85 cm, 1.1 cm) and obturator region (0.8 cm, 1.0 cm), respectively (table 3). In the internal iliac region, median diameter of the largest metastasis was significantly lower than in the other two regions (0.6 cm; p<0.03), and median total diameter of all metastases was only significantly lower compared with the external iliac region (0.8 cm; p<0.05).

Lymph node counts and nodal tumour burden stratified for gender

Lymph node distribution in the three pelvic regions, and the frequency, distribution or diameter of metastases, were not significantly different between women and men (table 4).
Table 4

Analysis of pelvic lymph nodes and characteristics of metastases stratified by gender and pelvic regions did not yield significant differences

External iliac regionObturator regionInternal iliac region
WomenMenWomenMenWomenMen
Median no. of nodes, (per patient range)8 (0–40)8.5 (0–43)10.5 (0–34)8 (0–30)5 (0–15)6 (0–18)
Median no. of metastases, (per patient range)2 (1–4)1 (1–9)2 (1–10)1 (1–23)1 (1–6)1 (1–13)
Median diameter (cm) of largest metastasis, (per patient range)0.6 (0.1–4.0)1.0 (0.1–4.9)0.8 (0.1–4.9)0.8 (0.1–4.9)0.6 (0.1–1.2)0.6 (0.1–4.9)
Median total diameter (cm) of all metastases, (per patient range)0.8 (0.1–7.0)1.58 (0.1–10.5)0.9 (0.1–14.2)1.1 (0.1–22.9)0.7 (0.1–3.1)0.8 (0.1–7.9)
Analysis of pelvic lymph nodes and characteristics of metastases stratified by gender and pelvic regions did not yield significant differences

Discussion

Differences in the surgical protocols for pelvic lymph node dissection might influence lymph node counts in lymphadenectomy specimens and tumour clearance in the pelvis.4 In particular, the clearance of lymph nodes from the internal iliac region is controversial. Our single institution series of patients treated uniformly by cystectomy and bilateral extended pelvic lymph node dissection for urothelial cancer of the bladder allows us to describe pelvic lymph node distribution and to quantify nodal tumour burden, reflected by number of positive nodes, diameter of largest metastasis and total diameter of all metastases. In line with Leissner et al2 and Abol-Enein et al1 a median of 25 pelvic lymph nodes per patient were dissected. Similar proportions of lymph nodes were found in the external iliac (39%) and obturator region (35%), and 26% of all nodes were present in the internal iliac region. Consequently, a limited pelvic lymphadenectomy without dissection of the internal iliac region could potentially miss one in four lymph nodes, resulting in less accurate staging. Lymph node tumour burden, reflected by number of positive lymph nodes, was not significantly different between the three pelvic regions. The external iliac, obturator and internal iliac region harboured 33%, 38% and 29% of all pelvic lymph node metastases, respectively. These findings are in accordance with the only other study evaluating such distribution.2 However, the median diameter of the largest metastasis and median total diameter of all metastases per patient were substantially smaller in the internal iliac region (0.6 cm, 0.8 cm) when compared with the external iliac (0.85 cm, 1.1 cm) and the obturator (0.8 cm, 1.0 cm) region. Importantly, 50% of all patients had lymph node metastases in the internal iliac region comprising 10% with isolated metastases. Consequently, a limited pelvic lymphadenectomy not including the internal iliac region would incompletely remove pelvic lymph node metastases in half of the nodal-positive patients with bladder cancer. This is of high clinical relevance, since up to 30% of these patients can be cured by cystectomy and extended lymphadenectomy.3 5 Recent series on gender-specific pelvic cancers suggest differences in pelvic lymph node counts between women (median, 25–38)7–9 and men (median, 8–22).5 13–15 Data on numbers of negative and positive pelvic lymph nodes in a mixed cohort treated for the same cancer are missing. We could not detect differences in lymph node counts or nodal tumour burden between the genders. Therefore, the above-mentioned differences might primarily indicate variations in the surgical procedure. In conclusion, pathologists and urologists should realise that retrieval of pelvic lymph nodes and metastases largely depends on the extent of lymphadenectomy. Excluding the internal iliac region from pelvic lymphadenectomy is associated with incomplete clearance of positive lymph nodes in 50% of the node positive patients, leaves approximately 29% of all lymph node metastases in situ, and understages 10% of the patients as pN0. In this cohort, no difference in lymph node parameters was detected between women and men. The surgical field of lymphadenectomy in urothelial cancer of the bladder is controversial, particularly the dissection of the internal iliac region. Limited lymphadenectomy not comprising the internal iliac region: (1) is associated with incomplete clearance of positive lymph nodes in 50% of the lymph node positive patients, (2) leaves approximately 29% of all pelvic lymph node metastases in situ, (3) understages 10% of the patients as pN0.
  14 in total

1.  Outcomes of Gleason score 10 prostate carcinoma treated by radical prostatectomy.

Authors:  Brant A Inman; David S DiMarco; Jeffrey M Slezak; Thomas J Sebo; Eugene D Kwon; Bradley C Leibovich; Michael L Blute; Horst Zincke
Journal:  Urology       Date:  2006-09-18       Impact factor: 2.649

2.  Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

Authors:  J P Stein; G Lieskovsky; R Cote; S Groshen; A C Feng; S Boyd; E Skinner; B Bochner; D Thangathurai; M Mikhail; D Raghavan; D G Skinner
Journal:  J Clin Oncol       Date:  2001-02-01       Impact factor: 44.544

3.  Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor.

Authors:  Achim Fleischmann; George N Thalmann; Regula Markwalder; Urs E Studer
Journal:  J Clin Oncol       Date:  2005-04-01       Impact factor: 44.544

4.  Anatomical study of para-aortic and pelvic lymph nodes in gynecologic malignancies.

Authors:  P B Panici; G Scambia; G Baiocchi; G Matonti; A Capelli; S Mancuso
Journal:  Obstet Gynecol       Date:  1992-04       Impact factor: 7.661

Review 5.  Indications, extent, and benefits of pelvic lymph node dissection for patients with bladder and prostate cancer.

Authors:  Ramesh Thurairaja; Urs E Studer; Fiona C Burkhard
Journal:  Oncologist       Date:  2009-01-14

6.  Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study.

Authors:  J Leissner; M A Ghoneim; H Abol-Enein; J W Thüroff; L Franzaring; M Fisch; H Schulze; G Managadze; E P Allhoff; M A el-Baz; H Kastendieck; P Buhtz; S Kropf; R Hohenfellner; H K Wolf
Journal:  J Urol       Date:  2004-01       Impact factor: 7.450

Review 7.  Update on lymphadenectomy in early and advanced ovarian cancer.

Authors:  Roberto Angioli; Francesco Plotti; Innocenza Palaia; Marco Calcagno; Roberto Montera; Ester Valentina Cafà; Maria Isabella Sereni; Pierluigi Benedetti Panici
Journal:  Curr Opin Obstet Gynecol       Date:  2008-02       Impact factor: 1.927

8.  Outcome after radical cystectomy with limited or extended pelvic lymph node dissection.

Authors:  Nivedita Bhatta Dhar; Eric A Klein; Alwyn M Reuther; George N Thalmann; Stephan Madersbacher; Urs E Studer
Journal:  J Urol       Date:  2008-01-25       Impact factor: 7.450

9.  Experience in 100 patients with an ileal low pressure bladder substitute combined with an afferent tubular isoperistaltic segment.

Authors:  U E Studer; H Danuser; V W Merz; J P Springer; E J Zingg
Journal:  J Urol       Date:  1995-07       Impact factor: 7.450

10.  Prostate specific antigen progression in men with lymph node metastases following radical prostatectomy: results of long-term followup.

Authors:  Ganesh S Palapattu; Mohamad E Allaf; Bruce J Trock; Jonathan I Epstein; Patrick C Walsh
Journal:  J Urol       Date:  2004-11       Impact factor: 7.450

View more
  10 in total

Review 1.  [Lymphadenectomy for bladder cancer: current status and controversies].

Authors:  T Metzger; G N Thalmann; P Zehnder
Journal:  Urologe A       Date:  2012-03       Impact factor: 0.639

Review 2.  Lymph node dissection during radical cystectomy for bladder cancer treatment: considerations on relevance and extent.

Authors:  Lars Weisbach; Roland Dahlem; Giuseppe Simone; Jens Hansen; Armin Soave; Oliver Engel; Felix K Chun; Shahrokh F Shariat; Margit Fisch; Michael Rink
Journal:  Int Urol Nephrol       Date:  2013-07-25       Impact factor: 2.370

3.  Role of pelvic lymphadenectomy in the treatment of bladder cancer: a mini review.

Authors:  Ja Hyeon Ku
Journal:  Korean J Urol       Date:  2010-06-21

4.  Pattern of lymph node metastasis correlates with tumor location in bladder cancer.

Authors:  Won Kyu Park; Young Sig Kim
Journal:  Korean J Urol       Date:  2012-01-25

5.  Pelvic lymphadenectomy in the treatment of invasive bladder cancer: literature review.

Authors:  Ehab A Elzayat; Ali A Al-Zahrani
Journal:  Adv Urol       Date:  2011-08-29

6.  Lymphadenectomy in management of invasive bladder cancer.

Authors:  Ramy F Youssef; Ganesh V Raj
Journal:  Int J Surg Oncol       Date:  2011-06-16

7.  Contrast enhanced computed tomography characterization of fluorodeoxygluocose-avid regional and non-regional lymph nodes in patients with suspicion of metastatic bladder cancer.

Authors:  Muhammad A Chaudhry; Richard Wahl; Lujaien Al-Rubaiey Kadhim; Atif Zaheer
Journal:  J Clin Imaging Sci       Date:  2013-12-31

8.  Pelvic lymph node dissection in the context of radical cystectomy: a thorough insight into the connection between patient, surgeon, pathologist and treating institution.

Authors:  Roland Seiler; George N Thalmann; Pascal Zehnder
Journal:  Res Rep Urol       Date:  2013-08-12

Review 9.  The Usefulness of Lymphadenectomy in Bladder Cancer-Current Status.

Authors:  Bartosz Małkiewicz; Paweł Kiełb; Adam Gurwin; Klaudia Knecht; Karol Wilk; Jakub Dobruch; Romuald Zdrojowy
Journal:  Medicina (Kaunas)       Date:  2021-04-25       Impact factor: 2.430

10.  Downregulation of GAS5 promotes bladder cancer cell proliferation, partly by regulating CDK6.

Authors:  Zhihong Liu; Wei Wang; Juntao Jiang; Erdun Bao; Dongliang Xu; Yigang Zeng; Le Tao; Jianxin Qiu
Journal:  PLoS One       Date:  2013-09-17       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.